Cigna Corp vs Sanofi SA — how do they compare? Cigna Corp trades at $273 (market cap $73.56B), while Sanofi SA trades at $43.25 (market cap $104.57B). The key difference: Sanofi SA is the larger of the two by market cap, and Sanofi SA pays the higher dividend (5.56%). Which is the better fit depends on your goals.
| CI | SNY | |
|---|---|---|
Market Cap | $73.56B | $104.57B |
Sector | Health | Health |
52-Week High | $311.00 | $52.34 |
52-Week Low | $244.41 | $41.33 |
Enterprise Value | $98.27B | $124.48B |
Dividend Yield | 2.24% | 5.56% |
Trailing returns across standard periods
Latest headlines on both assets
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →